MURRIETA, CA – Nov 13, 2018 – John Powers, co-founder and President of Murrieta Genomics, LLC, the Southern California genomic sequencing business incubator, is pleased to announce that Gene Tox Lab Solutions, LLC has been accepted into the their incubator program.
Co-Founders and Managing Partners Catherine Rells, CEO, Dr. Steven Ross, CMO and Dr. James Padilla, COO noted a few of the benefits of joining Murrieta Genomics. “We had several conversations with the founders of Murrieta Genomics and realized that being able to access both science and business experience of not only the principals but the advisory board that they have assembled, would be quite advantageous. Also, we are not spending resources trying to build a lab and hire experts to develop our genomic panels. We anticipate an accelerated launch with Murrieta Genomics as a strategic partner.”
Gene Tox is working on providing solutions to assist healthcare organizations including hospitals and clinics to manage their patient population through specialized lab testing, informatics, and education, all while lowering healthcare costs and increasing revenue.
According to Catherine. Rells, CEO, “It is estimated that half of all medical expenditures are squandered because of repeat procedures, the expenses associated with traditional methods of sharing information, delays in care, errors in care or delivery, and the like. We want to provide the solutions that can curb these costs. Incorporating health informatics reduces errors, increases communication, and drives efficiency.”
“By incorporating genomic sequencing data into patients’ records, doctors can have a clearer view into each patient’s risk factors – leading to the more accurate identification, prevention and treatment recommendations,” stated Mr. Powers. “Our goal is to help Gene Tox develop the panels that can provide the kinds of insight that doctors need to achieve better outcomes – reducing the cost of care at the same time.”
About Murrieta Genomics, LLC
Murrieta Genomics provides access to next-generation sequencing technology for researchers in the health, veterinary, agriculture, forensics and direct to consumer industries. The company is a true business incubator, offering mentorship and guidance from both the scientific and business perspective to aspiring genomic-related entrepreneurs. The four founding principals of Murrieta Genomics have an extensive background in business, finance, science, and technology. They are supplemented with an advisory board and local mentors from both business and science. In addition to low-cost incubation, the company provides hands-on consulting and will provide seed funding to qualified incubator graduates and connections to next-stage funders.
For more information visit www.murrietagenomics.com.
About Gene Tox Lab Solutions, LLC
Gene Tox Lab Solutions mission is to improve patient care by providing quality lab testing services, optimal therapy, reducing traditional trial and error approaches to prescribing medication, reducing adverse drug reactions, improving the selection of drug targeting, and improving drug compliance while providing healthcare professionals with the first user-friendly reporting for genetic, toxicology and pharmacogenomic testing. The Company offers the first comprehensive, turnkey solution to genetic, pharmacogenomic, toxicology testing and data solution implementation through cutting-edge testing abilities, customized service offerings, and industry-leading patient data interpretation solutions.
For more information visit www.genetoxlabsolutions.com.
Contact:
Jay Goth, Murrieta Genomics
951.704.6792
jgoth@murrietagenomics.com
drross@genetoxlabsolutions.com
Media Contact
Company Name: Gene Tox Lab Solutions
Contact Person: Steven Ross
Email: Send Email
Phone: 858-205-9735
Country: United States
Website: www.genetoxlabsolutions.com